Are the changes in pharmaceutical marketing affecting you?
Significant trends are shaping the pharmaceutical industry today, including: the end of the era of blockbuster drugs, growth in specialist-driven drug development, and a shift in the information needs of physicians. The world of pharmaceutical marketing continues to evolve with these changes, particularly in how communications occur with physicians, patients, and even payers.

Event Topic for May

The Next Generation Approach to Pharmaceutical Marketing
Come to Marketing Mondays to hear Liz Cermak, POZEN Inc. Chief Commercial Officer (and 25-year JNJ marketing veteran), speak about how the Chapel Hill-based specialty pharmaceutical company is transforming the traditional pharma marketing model to deliver better, more affordable medicines to patients and physicians in more efficient and effective ways previously not possible.

Over the past few years, it has become evident that the traditional “feet on the street” selling model is no longer working. Sales rep access to and time with prescribers continues to decrease, while physicians’ use of mobile and digital media for pharmaceutical information continues to rise. What has also become evident is that patients and payers are becoming increasingly price sensitive to high priced, branded pharmaceutical products.

It is with this backdrop that POZEN plans to transform the commercial pharmaceutical model with a strategy of affordable medicines and balancing a “High Touch” and “High Tech” communications approach.

As Chief Commercial Officer of POZEN, Cermak is leading the charge behind the commercialization of POZEN’s PA franchise, a portfolio of integrated treatments designed to enable the full power of aspirin by reducing its gastrointestinal (GI) toxicity.

Come hear her fascinating point of view on what’s broken in the pharmaceutical industry and how companies like POZEN plan to fix it.

Please join us for a networking reception following the presentation.

Speaker Bio
Liz Cermak
Ms. Cermak is Executive Vice President, Chief Commercial Officer at Pozen.

Prior to joining Pozen, Cermak was Worldwide Vice President for Johnson & Johnson and served in a variety of senior leadership roles across the pharmaceutical, consumer products and health management businesses. She has spent over 25 years in the healthcare industry and has led a number of Marketing and Sales organizations, most notably the $1.0B Women’s Health business at Ortho-McNeil Pharmaceuticals, Inc. Her RX and Consumer Products experience spans a number of therapeutic areas, including contraception, urology, pain, GI, CNS, anti-infectives, eye care and hair loss, with a successful track record of launching new products and growing and globalizing brands. Prior to this, Cermak was a senior management consultant for what is now Deloitte.